Semax is a synthetic research peptide composed of seven amino acids and derived from a fragment of adrenocorticotropic hormone (ACTH). Unlike the parent hormone, Semax has primarily been investigated for its interactions with neurological signaling pathways and has become an area of laboratory research involving neurotrophic factors, neuronal communication, neurotransmitter activity, and cellular responses within the nervous system.

Semax research has explored its relationship with neurotrophic signaling, including biological pathways associated with brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). Researchers have examined these mechanisms in experimental models involving neuronal plasticity, cellular communication, and adaptive responses within neural tissue.

Another significant area of Semax research involves neurotransmitter systems and gene expression. Laboratory studies have investigated its relationship with dopaminergic and serotonergic signaling, oxidative processes, and molecular mechanisms associated with neuronal function and cellular response to neurological stress.

Semax has a molecular weight of approximately 813.9 g/mol and can be synthetically produced for controlled research applications. It is typically supplied as a lyophilized powder for laboratory investigation involving neurotrophic signaling, neuronal biology, and related cellular pathways.